CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics
CTMX Price/Volume Stats
Current price | $0.80 | 52-week high | $5.85 |
Prev. close | $0.83 | 52-week low | $0.75 |
Day low | $0.79 | Volume | 885,300 |
Day high | $0.84 | Avg. volume | 926,927 |
50-day MA | $0.98 | Dividend yield | N/A |
200-day MA | $1.31 | Market Cap | 62.32M |
CTMX Stock Price Chart Interactive Chart >
CytomX Therapeutics, Inc. (CTMX) Company Bio
CytomX Therapeutics develops a novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology. The company was founded in 2008 and is based in San Francisco, California.
CTMX Price Returns
1-mo | -4.76% |
3-mo | -7.32% |
6-mo | -35.48% |
1-year | -45.58% |
3-year | -80.49% |
5-year | -89.50% |
YTD | -22.33% |
2024 | -33.55% |
2023 | -3.13% |
2022 | -63.05% |
2021 | -33.89% |
2020 | -21.18% |
Continue Researching CTMX
Want to do more research on CytomX Therapeutics Inc's stock and its price? Try the links below:CytomX Therapeutics Inc (CTMX) Stock Price | Nasdaq
CytomX Therapeutics Inc (CTMX) Stock Quote, History and News - Yahoo Finance
CytomX Therapeutics Inc (CTMX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...